Killer T-cells found to counter obesity-related diabetes

May 8, 2012 By Krishna Ramanujan
The two images show histological sections of white fat tissues from mice; the top panel shows tissues have been injected with the compound α-galactosylceramide that activates NKT cells (stained blue); image below is a control. (Qi Lab)

(Medical Xpress) -- For years, researchers have known that obesity, type 2 diabetes and low-level inflammation are linked, but how they are connected has not been well understood.

A recent Cornell-led study has found that a type of -- called natural killer T (NKT) cells -- is an important part of the puzzle.

Two hallmarks of diabetes include insulin resistance, the inability to effectively respond to insulin to control blood sugar, and , the inability to metabolize glucose.

(Qi Lab)

"When tissue is inflamed, it becomes insulin resistant," said Ling Qi, assistant professor of nutritional sciences.

The study found, however, that "activation of NKT cells reduces inflammation, and also reduces insulin resistance and increases ," added Qi, senior author of the study published April 20 in the . Yewei Ji, a postdoctoral researcher in Qi's lab, is the paper's lead author.

In the study, team members at the University of Hong Kong examined tissues from 39 healthy premenopausal Chinese and correlated the NKT cell levels with the women's (BMI). They found that as BMI increased, NKT cell levels in adipose (fat) tissue decreased significantly.

"The mechanism for that is not clear," said Qi, "but it points to the significance of our study that you need to activate these cells to have some sort of impact."

At Cornell, Qi and colleagues injected mice that were fed Western-type diets --where 60 percent of calories come from fat -- with a lipid compound (α-galactosylceramide) that is known to strongly and specifically activate NKT cells. The result: The inflammation and degrees of and glucose intolerance in the mice fell.

"The mice were eating a Western diet but their metabolic response was closer to mice that were eating a healthy diet," Qi said.

Next, the researchers plan to alter the regimen of lipid treatment to see if they can induce an even better effect in animals and try to identify compounds in foods that naturally activate NKT cells in humans. The researchers hope to identify particular foods that obese diabetics could eat to achieve the positive effects.

A patent has been filed as a result of this study.

Co-authors include researchers from the University of Hong Kong, Harvard University's School of Public Health, the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health, and Wageningen University in the Netherlands.

The study was funded by the National Institutes of Health, Hong Kong Collaborative Research Fund, Netherlands Nutrigenomics Center, Cornell, Howard Hughes Medical Institute, and the American Diabetes Association.

Explore further: Early research shows dietary supplement may lower risk of developing type 2 diabetes

Related Stories

Early research shows dietary supplement may lower risk of developing type 2 diabetes

September 22, 2011
UCLA researchers demonstrated that an over-the-counter dietary supplement may help inhibit development of insulin resistance and glucose intolerance, conditions that are involved in the development of Type 2 diabetes and ...

Infection is an important post-stroke problem

October 26, 2011
After a stroke the brain tries to protect itself by blocking all inflammation. However, this also makes the patient highly susceptible to infection which can lead to death. Researchers have now discovered the mechanism behind ...

Enzyme boosts metabolism, prevents weight gain in mice

November 14, 2011
In a new study, scientists report that they substantially curbed weight gain, improved metabolism, and improved the efficacy of insulin in mice by engineering them to express a specific human enzyme in their fat tissue. Although ...

Recommended for you

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.